Pediatric Neurology
Volume 25, Issue 2 , Pages 156-161 , August 2001

hGFRα-4: a new member of the GDNF receptor family and a candidate for NBIA

  • Bing Zhou, PhD

      Affiliations

    • Howard Hughes Medical Institute and Department of Medicine and Pediatrics; University of California; San Francisco, California, USA
  • ,
  • Sylvia K Bae, BA

      Affiliations

    • Department of Molecular and Medical Genetics; Oregon Health Sciences University; Portland, Oregon, USA
  • ,
  • Amy C Malone, BA

      Affiliations

    • Department of Molecular and Medical Genetics; Oregon Health Sciences University; Portland, Oregon, USA
  • ,
  • Barbara B Levinson, MS

      Affiliations

    • Howard Hughes Medical Institute and Department of Medicine and Pediatrics; University of California; San Francisco, California, USA
  • ,
  • Yien-Ming Kuo, PhD

      Affiliations

    • Howard Hughes Medical Institute and Department of Medicine and Pediatrics; University of California; San Francisco, California, USA
  • ,
  • M.Roberta Cilio, MD

      Affiliations

    • Neurophysiology Unit; Bambino Gesus Children’s Hospital; 00165 Rome, Italy
  • ,
  • Enrico Bertini, MD

      Affiliations

    • Neurophysiology Unit; Bambino Gesus Children’s Hospital; 00165 Rome, Italy
  • ,
  • Susan J Hayflick, MD

      Affiliations

    • Department of Molecular and Medical Genetics; Oregon Health Sciences University; Portland, Oregon, USA
  • ,
  • Jane M Gitschier, PhD

      Affiliations

    • Howard Hughes Medical Institute and Department of Medicine and Pediatrics; University of California; San Francisco, California, USA
    • Corresponding Author InformationCommunications should be addressed to: Dr. Gitschier; Howard Hughes Medical Institute and Department of Medicine and Pediatrics; University of California; San Francisco, CA94143

Received 26 September 2000 ,Accepted 11 December 2000.

References 

  1. Olson L. The coming of age of the GDNF family and its receptors (Gene delivery in a rat Parkinson model may have clinical implications). Trends Neurosci. 1997;20:277–279
  2. Grondin R, Gash DM. Glial cell line-derived neurotrophic factor (GDNF) (A drug candidate for the treatment of Parkinson’s disease). J Neurol. 1998;245(11 Suppl 3):35–42
  3. Jing S, Wen D, Yu Y, et al.  GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNFR-alpha, a novel receptor for GDNF. Cell. 1996;85:1113–1124
  4. Treanor JJ, Goodman L, de Sauvage F, et al.  Characterization of a multicomponent receptor for GDNF. Nature. 1996;382:80–83
  5. Baloh RH, Tansey MG, Golden JP, et al.  TrnR2, a novel receptor that mediates neurturin and GDNF signaling through Ret. Neuron. 1997;18:793–802
  6. Baloh RH, Gorodinsky A, Golden JP, et al.  GFRalpha3 is an orphan member of the GDNF/neurturin/persephin receptor family. Proc Natl Acad Sci USA. 1998;95:5801–5806
  7. Jing S, Yu Y, Fang M, et al.  GFRalpha-2 and GFRalpha-3 are two new receptors for ligands of the GDNF family. J Biol Chem. 1997;272:33111–33117
  8. Klein RD, Sherman D, Ho WH, et al.  A GPI-linked protein that interacts with Ret to form a candidate neurturin receptor. Nature. 1997;387:717–721
  9. Naveilhan P, Baudet C, Mikaels A, Shen L, Westphal H, Ernfors P. Expression and regulation of GFRalpha3, a glial cell line-derived neurotrophic factor family receptor. Proc Natl Acad Sci USA. 1998;95:1295–1300
  10. Sanicola M, Hession C, Worley D, et al.  Glial cell line-derived neurotrophic factor-dependent RET activation can be mediated by two different cell-surface accessory proteins. Proc Natl Acad Sci USA. 1997;94:6238–6243
  11. Dey BK, Wong YW, Too HP. Cloning of a novel murine isoform of the glial cell line-derived neurotrophic factor receptor. Neuroreport. 1998;9:37–42
  12. Masure S, Cik M, Pangalos MN, et al.  Molecular cloning, expression and tissue distribution of glial-cell-line-derived neurotrophic factor family receptor alpha-3 (GFRalpha-3). Eur J Biochem. 1998;251:622–630
  13. Nomoto S, Ito S, Yang LX, Kiuchi K. Molecular cloning and expression analysis of GFR alpha-3, a novel cDNA related to GDNFR alpha and NTNR alpha. Biochem Biophys Res Commun. 1998;244:849–853
  14. Thompson J, Doxakis E, Pinon LG, et al.  GFRalpha-4, a new GDNF family receptor. Mol Cell Neurosci. 1998;11:117–126
  15. Worby CA, Vega QC, Chao HH, Seasholtz AF, Thompson RC, Dixon JE. Identification and characterization of GFRalpha-3, a novel Co-receptor belonging to the glial cell line-derived neurotrophic receptor family. J Biol Chem. 1998;273:3502–3508
  16. Wang CY, Ni J, Jiang H, et al.  Cloning and characterization of glial cell line-derived neurotrophic factor receptor-B (A novel receptor for members of glial cell line-derived neurotrophic factor family of neurotrophic factors). Neuroscience. 1998;83:7–14
  17. Widenfalk J, Nosrat C, Tomac A, Westphal H, Hoffer B, Olson L. Neurturin and glial cell line-derived neurotrophic factor receptor-beta (GDNFR-beta), novel proteins related to GDNF and GDNFR-alpha with specific cellular patterns of expression suggesting roles in the developing and adult nervous system and in peripheral organs. J Neurosci. 1997;17:8506–8519
  18. Kotzbauer PT, Lampe PA, Heuckeroth RO, et al.  Neurturin, a relative of glial-cell-line-derived neurotrophic factor. Nature. 1996;384:467–470
  19. Buj-Bello A, Adu J, Pinon LG, et al.  Neurturin responsiveness requires a GPI-linked receptor and the Ret receptor tyrosine kinase. Nature. 1997;387:721–724
  20. Baloh RH, Tansey MG, Lampe PA, et al.  Artemin, a novel member of the GDNF ligand family, supports peripheral and central neurons and signals through the GFRalpha3-RET receptor complex. Neuron. 1998;21:1291–1302
  21. Enokido Y, de Sauvage F, Hongo JA, et al.  GFR alpha-4 and the tyrosine kinase Ret form a functional receptor complex for persephin. Curr Biol. 1998;8:1019–1022
  22. Milbrandt J, de Sauvage FJ, Fahrner TJ, et al.  Persephin, a novel neurotrophic factor related to GDNF and neurturin. Neuron. 1998;20:245–253
  23. Schuchardt A, D’Agati V, Larsson-Blomberg L, Costantini F, Pachnis V. Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret. Nature. 1994;367:380–383
  24. Sanchez MP, Silos-Santiago I, Frisen J, He B, Lira SA, Barbacid M. Renal agenesis and the absence of enteric neurons in mice lacking GDNF. Nature. 1996;382:70–73
  25. Pichel JG, Shen L, Sheng HZ, et al.  Defects in enteric innervation and kidney development in mice lacking GDNF. Nature. 1996;382:73–76
  26. Moore MW, Klein RD, Farinas I, et al.  Renal and neuronal abnormalities in mice lacking GDNF. Nature. 1996;382:76–79
  27. Cacalano G, Farinas I, Wang LC, et al.  GFRalpha1 is an essential receptor component for GDNF in the developing nervous system and kidney. Neuron. 1998;21:53–62
  28. Enomoto H, Araki T, Jackman A, et al.  GFR alpha1-deficient mice have deficits in the enteric nervous system and kidneys. Neuron 1998. 1998;21:317–324
  29. Romeo G, Ronchetto P, Luo Y, et al.  Point mutations affecting the tyrosine kinase domain of the RET proto-oncogene in Hirschsprung’s disease. Nature. 1994;367:377–378
  30. Edery P, Lyonnet S, Mulligan LM, et al.  Mutations of the RET proto-oncogene in Hirschsprung’s disease. Nature. 1994;367:378–380
  31. Ivanchuk SM, Myers SM, Eng C, Mulligan LM. De novo mutation of GDNF, ligand for the RET/GDNFR-alpha receptor complex, in Hirschsprung disease. Hum Mol Genet. 1996;5:2023–2026
  32. Salomon R, Attie T, Pelet A, et al.  Germline mutations of the RET ligand GDNF are not sufficient to cause Hirschsprung disease. Nat Genet. 1996;14:345–347
  33. Angrist M, Bolk S, Halushka M, Lapchak PA, Chakravarti A. Germline mutations in glial cell line-derived neurotrophic factor (GDNF) and RET in a Hirschsprung disease patient. Nat Genet. 1996;14:341–344
  34. Geneste O, Bidaud C, De Vita G, et al.  Two distinct mutations of the RET receptor causing Hirschsprung’s disease impair the binding of signalling effectors to a multifunctional docking site. Hum Mol Genet. 1999;8:1989–1999
  35. Dooling EC, Schoene WC, Ricardson EP. Hallervorden-Spatz Syndrome. Arch Neurol. 1974;30:70–83
  36. Taylor TD, Litt M, Kramer P, et al.  Homozygosity mapping of Hallervorden-Spatz syndrome to chromosome 20p12.3-p13. Nat Genet. 1996;14:479–481
  37. Gunn TM, Miller KA, He L, et al.  The mouse mahogany locus encodes a transmembrane form of human attractin. Nature. 1999;398:152–156
  38. Eng C, Myers SM, Kogon MD, et al.  Genomic structure and chromosomal localization of the human GDNFR-alpha gene. Oncogene. 1998;16:597–601
  39. Angrist M, Jing S, Bolk S, et al.  Human GFRA1 (Cloning, mapping, genomic structure, and evaluation as a candidate gene for Hirschsprung disease susceptibility). Genomics. 1998;48:354–362
  40. Udenfriend S, Kodukula K. How glycosylphosphatidylinositol-anchored membrane proteins are made. Annu Rev Biochem. 1995;64:563–591
  41. Airaksinen MS, Titievsky A, Saarma M. GDNF family neurotrophic factor signaling (Four masters, one servant?). Mol Cell Neurosci. 1999;13:313–325
  42. Virtaneva K, D’Amato E, Miao J, et al.  Unstable minisatellite expansion causing recessively inherited myoclonus epilepsy, EPM1. Nat Genet. 1997;15:393–396
  43. Lakich D, Kazazian HH, Antonarakis SE, Gitschier J. Inversions disrupting the factor VIII gene are a common cause of severe haemophilia A. Nat Genet. 1993;5:236–241
  44. Swaiman KF. Hallervorden-Spatz syndrome and brain iron metabolism. Arch Neurol. 1991;48:1285–1293
  45. Kuo YM, Gitschier J, Packman S. Developmental expression of the mouse mottled and toxic milk genes suggests distinct functions for the Menkes and Wilson disease copper transporters. Hum Mol Genet. 1997;6:1043–1049

PII: S0887-8994(00)00277-0

Pediatric Neurology
Volume 25, Issue 2 , Pages 156-161 , August 2001